Clinical Treatment of Pulmonary Infection Complicated with Severe Hypokalemia in Senile Inpatients with Cardiovascular Diseases
Objective To discuss the clinical treatment and curing measures for pulmonary infection complicated with severe hypokalemia in senile inpatients with cardiovascular diseases for the sake of improving the diagnosis and treatment level. Methods Clinical data of 68 senile inpatients with cardiovascular diseases who suffered from pulmonary infection complicated with severe hypokalemia collected from March, 2012 to February, 2015 were investigated and the patients were randomly divided into the control group and the observation group, 34 cases in each group. The observation group was given potassium chloride solution for supplementary treatment for potassium injected by micro pump through deep vein catheterization, while the control group was given 0.3% of potassium chloride solution for supplementary treatment for potassium by common intravenous infusion. Then the clinical effects, the improvement conditions of pulmonary infection and levels of serum potassium of patients in two groups were compared after the treatment. Results The effective rate of the observation group was 88.24% which was significantly higher than 67.65% of the control group (P<0.05). The levels of serum potassium before and after treatment were (2.18±0.15) mmol/L and (3.98±0.42) mmol/L in the observation group, and the levels of serum potassium before and after treatment were (2.46±0.15) mmol/L and (3.51±0.38)mmol/L in the control group. Obviously, the levels of serum potassium in observation group were higher than the levels in the control group and the differences between the two groups had statistical significance (P<0.05). Conclusion: The supplementary treatment for potassium operated by deep venous catheter and the treatment of potassium chloride solution injected by subclavian vein puncture can promote the effective rates of the treatment for pulmonary infection complicated with severe hypokalemia in senile inpatients with cardiovascular diseases, improve the quality of life of patients and be popularized and applied in the clinical treatment.